Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy

MLA

Shogo Numa, et al. “Five-Year Visual Outcomes after Anti-VEGF Therapy with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy.” The British Journal of Ophthalmology, vol. 103, no. 5, Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bd29bc274bc8f889734ab9ed123a3892&authtype=sso&custid=ns315887.

APA

Shogo Numa, Hiroshi Tamura, Munemitsu Yoshikawa, Masayuki Hata, Sotaro Ooto, Manabu Miyata, Akitaka Tsujikawa, Kenji Yamashiro, & Naoko Ueda-Arakawa. (2018). Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy. The British Journal of Ophthalmology, 103(5).

Chicago

Shogo Numa, Hiroshi Tamura, Munemitsu Yoshikawa, Masayuki Hata, Sotaro Ooto, Manabu Miyata, Akitaka Tsujikawa, Kenji Yamashiro, and Naoko Ueda-Arakawa. 2018. “Five-Year Visual Outcomes after Anti-VEGF Therapy with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy.” The British Journal of Ophthalmology 103 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bd29bc274bc8f889734ab9ed123a3892&authtype=sso&custid=ns315887.